All In Biotech

Drug Trial Radar · NCT07558733

Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer

Open-Label Umbrella Study to Evaluate Safety and Efficacy of Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced or Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

32

Planned (sponsor's estimate)

Start

Apr 22, 2026

Primary completion

May 2029

Study completion May 2033

Sponsor

Lead sponsor
Faeth TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 30, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a Phase 1b/2, multi-center, open-label, dose escalation trial evaluating the safety and preliminary efficacy of sapanisertib and serabelisib (PIKTOR) with fulvestrant and/or other anticancer therapies in participants with HR+/HER2- advanced/metastatic breast cancer.

Conditions

  • HR+ HER2- Breast Cancer

Interventions

  • SerabelisibDrug

    Serabelisib is a selective, small molecule inhibitor of PI3Kα.

  • SapanisertibDrug

    Sapanisertib is a small molecule inhibitor of the mammalian mTOR serine/threonine kinase.

  • FulvestrantDrug

    Fulvestrant is a first-in-class SERD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of drugs by assessment of adverse events (AEs) / serious adverse events (SAEs)Time frame: 2 years

Locations

9 sites in 1 country. Site status is shown where the registry gives one.

  • START Los Angeles

    Los Angeles, California · Recruiting

  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California · Recruiting

  • Rocky Mountain Cancer Centers

    Lone Tree, Colorado · Recruiting

  • Moffitt Cancer Center

    Tampa, Florida · Recruiting

  • Oncology Associates of Oregon

    Springfield, Oregon · Recruiting

  • SCRI Oncology Partners

    Nashville, Tennessee · Recruiting

  • Texas Oncology - Central/South

    Austin, Texas · Recruiting

  • START San Antonio

    San Antonio, Texas · Recruiting

  • Texas Oncology - San Antonio

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.